Federated Hermes, Inc. 13D and 13G filings for Fusion Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-08 09:10 am Sale |
2024-03-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
FEDERATED HERMES INC. FHI |
95,000 0.110% |
-10,621,153 (-99.11%) |
Filing |
| 2024-03-25 5:29 pm Sale |
2024-03-18 | 13D | Fusion Pharmaceuticals Inc. FUSN |
FEDERATED HERMES INC. FHI |
10,716,153 12.650% |
-170,000 (-1.56%) |
Filing |
| 2024-01-18 10:11 am Purchase |
2023-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
FEDERATED HERMES INC. FHI |
10,886,153 15.030% |
252,364 (+2.37%) |
Filing |
| 2023-06-09 08:19 am Purchase |
2023-05-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
FEDERATED HERMES INC. FHI |
10,633,789 16.660% |
7,409,689 (+229.82%) |
Filing |
| 2023-02-01 08:56 am Purchase |
2022-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
FEDERATED HERMES INC. FHI |
3,224,100 7.200% |
3,224,100 (New Position) |
Filing |